Document is current
Any future updates will be listed below
-
Authors
Ngwarai, Ngonidzashe https://orcid.org/0009-0004-8497-9080
Tluway, Furahini https://orcid.org/0000-0002-3130-3616
Mayindi, Nokthula
Mabasa, Jackson
Mashaba, Given
Khoza, Simon
Hove, Jennifer
Khoza, Dorcus
Wafawanaka, Floidy
Chipungu, Shingirai
Ndlovu, Dzunisani
Mdaka, Brian
Ngobeni, Tsakani
Phiri, Andrew
Tibane, Jeffrey
Gómez-Olivé, F. Xavier https://orcid.org/0000-0002-4876-0848
Tollman, Stephen https://orcid.org/0000-0003-0744-7588
Mkansi, Vukosi Nomses
Micklesfield, Lisa K. https://orcid.org/0000-0002-4994-0779
Manabile, Mmalehlokoana Maria
Choma, Solomon S. Rampai
Kasina, Prathap
Burke, Erin https://orcid.org/0000-0002-7559-4961
Ramsay, Michèle https://orcid.org/0000-0002-4156-4801
Fabian, June
LeBaron von Baeyer, Sarah https://orcid.org/0009-0005-0056-6201
-
Funding
Funding for this research was provided by:
Variant Bio
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 23 January 2026
First Online: 19 February 2026
Competing interests
: E.B., P.K., and S.L.v.B. are either current or former employees and options or shareholders of the US-based genomics-driven drug discovery company Variant Bio. M.R. is a consultant to Genetec (Roche) on Race, Ethnicity, and Ancestry: Application and Use in Clinical Trials and Product Development. The remaining authors declare no competing interests.
